The 2002 Canadian bone densitometry recommendations: take-home messages.
作者信息
Khan Aliya A, Brown Jacques P, Kendler David L, Leslie William D, Lentle Brian C, Lewiecki E Michael, Miller Paul D, Nicholson R Lawrence, Olszynski Wojciech P, Watts Nelson B
机构信息
Division of Geriatrics, McMaster University, Hamilton, ON.
出版信息
CMAJ. 2002 Nov 12;167(10):1141-5.
Abstract
摘要
相似文献
1
The 2002 Canadian bone densitometry recommendations: take-home messages.
CMAJ. 2002 Nov 12;167(10):1141-5.
2
Screening for osteoporosis in postmenopausal women: recommendations and rationale.
Am J Nurs. 2003 Jan;103(1):73-80; discussion 81.
3
Clinical practice. Screening for osteoporosis.
N Engl J Med. 2005 Jul 14;353(2):164-71. doi: 10.1056/NEJMcp042092.
4
Determinants of bone mineral density in older postmenopausal Chinese women.
Climacteric. 2011 Jun;14(3):378-83. doi: 10.3109/13697137.2010.548566. Epub 2011 Mar 15.
5
Postmenopausal osteoporosis.
Aust Fam Physician. 1993 Jun;22(6):987, 990-3.
6
Seeking clarification of osteoporosis guidelines.
CMAJ. 2004 Oct 26;171(9):1022; author reply 1022-3. doi: 10.1503/cmaj.1040953.
7
The distal radial fracture in elderly women and the bone mineral density of the lumbar spine and hip.
J Hand Surg Br. 2004 Oct;29(5):473-6. doi: 10.1016/j.jhsb.2004.05.002.
8
An overview of osteoporosis.
Altern Ther Health Med. 2004 Mar-Apr;10(2):26-33; quiz 34, 92.
9
Bone densitometry: an update.
Radiol Technol. 2003 Mar-Apr;74(4):321-38; quiz 339-41, 351.
10
Bone densitometry is not a good predictor of hip fracture.
BMJ. 2001 Oct 6;323(7316):797-9.
引用本文的文献
1
Spanish consensus on treat to target for osteoporosis.
Osteoporos Int. 2018 Feb;29(2):489-499. doi: 10.1007/s00198-017-4310-y. Epub 2017 Nov 24.
2
Risk of fractures and bone abnormalities in postmenopausal women with type 2 diabetes mellitus.
Clin Cases Miner Bone Metab. 2010 May;7(2):126-9.
3
Effect of Medicare reimbursement reduction for imaging services on osteoporosis screening rates.
J Am Geriatr Soc. 2012 Mar;60(3):511-6. doi: 10.1111/j.1532-5415.2011.03837.x. Epub 2012 Feb 13.
4
Asthma and therapeutics: inhaled corticosteroids, corticosteroid osteoporosis, and the risk of fracture in chronic asthma.
Allergy Asthma Clin Immunol. 2005 Mar 15;1(1):28-33. doi: 10.1186/1710-1492-1-1-28.
5
Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus.
J Natl Med Assoc. 2006 Oct;98(10):1598-604.
6
Canadian Consensus Conference on osteoporosis, 2006 update.
J Obstet Gynaecol Can. 2006 Feb;28(2 Suppl 1):S95-112. doi: 10.1016/s1701-2163(16)32087-4.
7
Osteoporosis in children and adolescents: etiology and management.
Paediatr Drugs. 2005;7(5):295-323. doi: 10.2165/00148581-200507050-00003.
8
Low bone mineral density is two to three times more prevalent in non-athletic premenopausal women than in elite athletes: a comprehensive controlled study.
Br J Sports Med. 2005 May;39(5):282-7; discussion 282-7. doi: 10.1136/bjsm.2004.012781.
9
Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care.
CMAJ. 2004 May 25;170(11):1665-7. doi: 10.1503/cmaj.1030757.
10
Adverse effects of antiretroviral therapy for HIV infection.
CMAJ. 2004 Jan 20;170(2):229-38.
本文引用的文献
1
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.
CMAJ. 2002 Nov 12;167(10 Suppl):S1-34.
2
Standards and guidelines for performing central dual X-ray densitometry from the Canadian panel of International Society for Clinical Densitometry.
J Clin Densitom. 2002 Fall;5(3):247-57. doi: 10.1385/jcd:5:3:247.
3
An assessment tool for predicting fracture risk in postmenopausal women.
Osteoporos Int. 2001;12(7):519-28. doi: 10.1007/s001980170072.
4
Reproducibility of DXA: potential impact on serial measurements and misclassification of osteoporosis.
Osteoporos Int. 2001;12(1):49-54. doi: 10.1007/s001980170157.
5
Assessing bone density in men.
J Bone Miner Res. 2000 Oct;15(10):1867-70. doi: 10.1359/jbmr.2000.15.10.1867.
6
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
Am J Med. 2000 Sep;109(4):267-76. doi: 10.1016/s0002-9343(00)00490-3.
7
An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation.
Osteoporos Int. 2000;11(3):192-202. doi: 10.1007/s001980050281.
8
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
JAMA. 1999 Aug 18;282(7):637-45. doi: 10.1001/jama.282.7.637.
9
Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Introduction.
Osteoporos Int. 1998;8 Suppl 4:S7-80.
10
Hip fracture prediction in elderly men and women: validation in the Rotterdam study.
J Bone Miner Res. 1998 Oct;13(10):1587-93. doi: 10.1359/jbmr.1998.13.10.1587.
Zotero 插件